This correlated with an approximately 50% decrease in Ki67 positive cells, indicating inhibitory effects of Sangivamycin on proliferating tumor cells (Fig. 5C and Fig. 5D, left bar graph). This evidence concerns the gene MKI67 and neoplasm.